China Digest: IDG Capital backs Lyvgen's Series C; VirtAI Tech bags over $10m

Biopharmaceutical firm Lyvgen has raised “tens of millions of US dollars” in a Series C round led by IDG Capital, while AI accelerator Beijing VirtAI Technology has pocketed a similar amount in its Series A+ round led by China Mobile’s joint fund.